HEALTH-2009-2.4.4-1
HEALTH-2009-2.4.4-1
7 projects · €40,669,743 total EU contribution (project-level) · 92 participating organizations · 20 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€40,669,743
Countries active
Participant organizations by country (headquarters in CORDIS).
- France (14)
- Italy (13)
- Germany (12)
- UK (10)
- Spain (7)
- US (7)
- Netherlands (5)
- CH (4)
- EL (3)
- IL (3)
- AT (2)
- BE (2)
- SE (2)
- AE (1)
- AU (1)
- DK (1)
- HU (1)
- NO (1)
- PT (1)
- TR (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- INSERM6 projects · FR
- UT3 projects · DE
- FINCB3 projects · IT
- UNIVERSITY COLLEGE LONDON3 projects · —
- AMC2 projects · NL
- Leiden University Medical Center2 projects · NL
- KU Leuven2 projects · BE
- MRC2 projects · UK
- OUS2 projects · NO
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE2 projects · UK
- UNIVERSITY OF MANCHESTER2 projects · UK
- TROPHOS2 projects · FR
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Nuclease Immune Mediated Brain and Lupus-like conditions (NIMBL): natural history, pathophysiology, diagnostic and therapeutic modalities with application to other disorders of autoimmunity NIMBL · 241779 | FP7 | €5,396,993 | €6,978,247 | Details |
Therapeutic challenge in Leukodystrophies: Translational and ethical research towards clinical trials LEUKOTREAT · 241622 | FP7 | €5,978,126 | €9,249,281 | Details |
Identifying and validating pre-clinical biomarkers for diagnostics and therapeutics of Neuromuscular Disorders BIO-NMD · 241665 | FP7 | €5,634,356 | €7,539,671 | Details |
European Friedreich's Ataxia Consortium for Translational Studies EFACTS · 242193 | FP7 | €5,983,379 | €7,934,618 | Details |
European Project on Mendelian Forms of Parkinson’s Disease MEFOPA · 241791 | FP7 | €5,759,468 | €8,053,959 | Details |
Myasthenias, a group of immune mediated neurological diseases: from etiology to therapy FIGHT-MG · 242210 | FP7 | €5,917,421 | €7,767,251 | Details |
Fighting blindness of Usher syndrome: diagnosis, pathogenesis and retinal treatment (TreatRetUsher) TREATRUSH · 242013 | FP7 | €6,000,000 | €8,181,653 | Details |